naringenin has been researched along with Sarcoma 180 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiura, T; Ishikawa, M; Kanno, S; Kimura, K; Ohtake, T; Osanai, Y; Shouji, A; Tomizawa, A; Ujibe, M | 1 |
1 other study(ies) available for naringenin and Sarcoma 180
| Article | Year |
|---|---|
Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavanones; Growth Inhibitors; Humans; Male; Mice; Sarcoma 180 | 2005 |